ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes

Biomedicine and Pharmacotherapy

Volumn 64, Issue 3, 2010, Pages 160-164

  Zha, Yanping ^a   Chen, Yong ^a   Xu, Fayun ^a   Li, Tian ^a   Zhao, Chuanyan ^a   Cui, Lianqun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Acute coronary syndromes; ADAMTS4; Coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; AGGRECANASE 1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; MATRIX METALLOPROTEINASE; NADROPARIN; NITRIC ACID DERIVATIVE; STREPTOKINASE; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME IMMUNOASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS; VENOUS BLOOD;

ACUTE CORONARY SYNDROME; ADAM PROTEINS; AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMORBIDITY; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCOLLAGEN N-ENDOPEPTIDASE; RUPTURE, SPONTANEOUS; TIME FACTORS; TROPONIN T;

EID: 77649232898     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.09.012     Document Type: Article

References (19)

1. Tang, BT. ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 2001;3:33-44.
2. Wågsäter D, Björk H, Zhu C, Björkegren J, Valen G, Hamsten A et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 2008;196:514-22.
3. SandyF J.D., Westling J., Richard D., Kenagy M., Iruela-Arispe L., Verscharen C., et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276 (2001) 13372-13378
4. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
5. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Steven D et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme (metalloelastase/metalloproteinase/chondroitin sulfate). Proc Natl Acad Sci U S A 1996;93:9748-53.
6. Joanna R., Baugh M.D., Dylan D.A., and Aileen R. Metalloproteinase expression in PMA-stimulated THP-1. J Biol Chem 278 (2003) 51340-51346
7. Zhang X.P., Kamata T., Yokoyama K., Puzon-McLaughlin W., and Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J Biol Chem 273 (1998) 7345-7350
8. Eto K, Huet C, Tarui T, Kupriyanov S, Liu HZ, Puzon-McLaug W et al. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J Biol Chem 2002;277:17804-10.
9. Reiss K., Ludwig A., and Saftig P. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 111 (2006) 985-1006
10. Guo N.H., Krutzsch H.C., Negre E., Zabrenetzky V.S., and Roberts D.D. Heparin-binding peptides from the type-I repeats of thrombospondin structural requirements for heparin-binding and promotion of melanoma cell-adhesion and chemotaxis. J Biol Chem 267 (1992) 19349-19355
11. Guo N.H., Krutzsch H.C., Negre E., Vogel T., Blake D.A., and Roberts D.D. Heparin-binding and sulfatide-binding peptides from the type-I repeats of human thrombospondin promote melanoma cell adhesion. Proc Natl Acad Sci U S A 89 (1992) 3040-3044
12. Tortorella M, Pratta M, Liu RQ, Abbaszade I, Ross H, Bur T, et al. The thrombospondin motif of aggrecanase -1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem 2000;275:25791-7.
13. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
14. Shah P.K. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev 8 (2000) 31-39
15. Virmani R., Burke A.P., and Farb A. Plaque rupture and plaque erosion. Thromb Haemost 82 Suppl. 1 (1999) 1-3
16. Davies M.J., Woolf N., Rowles P., and Richardson P.D. Lipid and cellular constituents of unstable human aortic plaques. Basic Res Cardiol 89 (1994) 33-39
17. Kenagy R.D., Plaas A.H., and Wight T.N. Versican degradation and vascular disease. Trends Cardiovasc Med 16 (2006) 209-215
18. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
19. Laine P., Kaartinen M., Penttilä A., Panula P., Paavonen T., and Kovanen P.T. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 99 (1999) 361-369